Introduction Recent advancements in the understanding of non-alcoholic fatty liver disease (NAFLD) have led to significant developments, including a change in its nomenclature to metabolic dysfunction-associated steatotic liver disease (MASLD). Other developments include recommendations for screening in patients with type 2 diabetes mellitus (T2DM)
2986 Reached10 Comments4 Likes
Complicated case of Osteoarthritis
1850 Reached2 Comments3 Likes
Woman presented with Fever of Unknown Origin
7735 Reached93 Comments19 Likes
Case of Pulmonary Embolism with Syncope
544 Reached4 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes
Case of Adolescent with Severe Macrocytic Anaemia
52965 Reached501 Comments51 Likes